PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, will hold a conference call on November 12, 2010 to discuss the financial results for the third quarter ended September 30, 2010. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
